Sequence announces our new website and logo

Read
All Projects

Project GTx

Cell & Gene Therapy

Overview

The Pfizer Sanford site is home to the state-of-the-art gene therapy manufacturing facility, which provides the ability to produce and supply both clinical and commercial scale quantities of critical life-changing gene therapy medicines to patients living with rare diseases around the world.

Sequence Scope

This project involved a full C&Q scope for Gene Therapy Equipment Verification which included the facilities, utilities, equipment, computerized systems, and labs. Sequence was responsible for developing the CQV strategy and planning, developing requirement specifications, and all CQV deliverables to demonstrate the facility was fit for intended use to produce potentially life-changing gene therapy products.Facility included Incubators, GE XDR Bioreactors, GE Wave Rockers, Perfusion Skids, GE Chromatography Skids, Filtration Skids, Bio-waste systems, Autoclaves, Buffer Prep, Biosafety Cabinets, Isolators, Fillers, and supporting utilities.

Life Impact

  • By expanding its manufacturing footprint in Sanford, Pfizer expects to strengthen its ability to produce and supply both clinical- and commercial-scale quantities of critical, potentially life-changing gene therapy medicines to patients living with rare diseases around the world. Specifically, the new facility helps advance Pfizer’s work in manufacturing highly specialized, potentially one-time gene therapies that use custom-made recombinant adeno-associated virus (rAAV) vectors. Source

  • This includes gene therapy for Duchenne Muscular Dystrophy. Press Release

Get Started

How can we support your project success?

Contact Us
855.844.7171 info@sequenceQCS.com
  • Global Headquarters
    2100 Gateway Center Blvd, Suite 301
    Morrisville, NC 27560

  • Lab and Training Center
    2500 Gateway Center Blvd, Suite 850
    Morrisville, NC 27560

  • Northeast Office
    1 Speen Street, Suite 120
    Framingham, MA 01701

Sign up for our email newsletter

Accelerating time to market through proven quality and compliance solutions.

© 2021 Sequence, Inc. All rights reserved.